Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» patents
patents
Amgen loses appeal in patent suit against Sanofi/Regeneron’s Praluent. It’s a bummer for Bristol Myers Squibb and Merck, too
Amgen loses appeal in patent suit against Sanofi/Regeneron’s Praluent. It’s a bummer for Bristol Myers Squibb and Merck, too
Endpoints
Amgen
patents
Sanofi
Regeneron
Praluent
Repatha
Merck
Flag link:
What does Brexit mean for biopharma companies?
What does Brexit mean for biopharma companies?
Biopharma Reporter
Brexit
UK
Europe
patents
Flag link:
Which pharmaceutical drugs have the most patents?
Which pharmaceutical drugs have the most patents?
Drug Patent Watch
patents
Flag link:
Merck comes up short in last-ditch effort to revive $2.54B patent verdict against Gilead
Merck comes up short in last-ditch effort to revive $2.54B patent verdict against Gilead
Fierce Pharma
Merck
Idenis
Gilead Sciences
patents
Harvoni
Sovaldi
Flag link:
Amarin vs. the Generics: Who Will Win?
Amarin vs. the Generics: Who Will Win?
Motley Fool
Amarin
generics
Vascepa
patents
Flag link:
Major generic makers will partner with Medicines Patent Pool to pursue voluntary licenses for Covid-19 drugs
Major generic makers will partner with Medicines Patent Pool to pursue voluntary licenses for Covid-19 drugs
Stat
generics
patents
Flag link:
Testing requirements are likely slowing biosimilar entries in the US
Testing requirements are likely slowing biosimilar entries in the US
RAPS.org
biosimilars
regulatory
patents
drug rebates
Flag link:
Covid-19 Vaccine Frontrunner Moderna Won’t Enforce Vaccine Patents During Pandemic
Covid-19 Vaccine Frontrunner Moderna Won’t Enforce Vaccine Patents During Pandemic
Forbes
Moderna Therapeutics
COVID-19
pandemic
vaccines
patents
Flag link:
Teva back on the hook for $235M to GSK for heart drug infringement
Teva back on the hook for $235M to GSK for heart drug infringement
Fierce Pharma
Teva
GSK
Patent Infringement
Coreg
generics
patents
Flag link:
Medtronic Takes the Gloves Off in Patent War with Axonics
Medtronic Takes the Gloves Off in Patent War with Axonics
Medical Devices and Diagnostics Industry
Medtronic
Axonics
devices
patents
sacral neuromodulation
InterStim
Flag link:
Amarin loses patent appeal and their brief grip on a cardiovascular, fish oil empire
Amarin loses patent appeal and their brief grip on a cardiovascular, fish oil empire
Endpoints
Amarin
Vascepa
patents
Flag link:
Amarin Patent Appeal Is a Coin Toss With Billions on the Line
Amarin Patent Appeal Is a Coin Toss With Billions on the Line
Yahoo/Bloomberg
Amarin
Vascepa
patents
Flag link:
AbbVie to face House committee subpoena over Humira, Imbruvica pricing strategies: chairwoman
AbbVie to face House committee subpoena over Humira, Imbruvica pricing strategies: chairwoman
Fierce Pharma
AbbVie
Imbruvica
Humira
drug pricing
patents
Flag link:
Moderna failed to disclose federal funding for vaccine patent applications, advocates say
Moderna failed to disclose federal funding for vaccine patent applications, advocates say
Stat
Moderna Therapeutics
patents
vaccines
Department of Defense
Flag link:
U.S. court upholds patent for Novartis MS drug Gilenya
U.S. court upholds patent for Novartis MS drug Gilenya
Reuters
Novartis
patents
Gilenya
MS
multiple sclerosis
Flag link:
Bristol Myers, Pfizer fend off a key challenge to their top-selling heart drug
Bristol Myers, Pfizer fend off a key challenge to their top-selling heart drug
BioPharma Dive
Bristol-Myers Squibb
Pfizer
patents
Eliquis
generics
Delaware
Flag link:
Chelation Partners Announces Issuance of U.S. Patent Covering Composition of Matter for DIBI and Related Compounds for Controlling Infections
Chelation Partners Announces Issuance of U.S. Patent Covering Composition of Matter for DIBI and Related Compounds for Controlling Infections
CP Wire
Chelation Partners
AMR
ACOA
Canada
antibiotics
antibiotic resistance
patents
Flag link:
Chelation Partners Announces Issuance of U.S. Patent Covering Composition of Matter for DIBI and Related Compounds for Controlling Infections
Chelation Partners
AMR
ACOA
Canada
antibiotics
antibiotic resistance
patents
Flag link:
Moderna's Vaccine Technology Continues to be Tangled in Patent Challenges
Moderna's Vaccine Technology Continues to be Tangled in Patent Challenges
BioSpace
Moderna Therapeutics
COVID-19
vaccines
mRNA-1272
patents
Arbutus BioPharma
Acuitas Pharma
Flag link:
Moderna's stock falls the day after 'disappointing' patent ruling
Moderna's stock falls the day after 'disappointing' patent ruling
Marketwatch
Moderna Therapeutics
Arbutus BioPharma
patents
vaccines
COVID-19
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »